Rosacea happens because of a chain reaction in the skin’s immune system, where an overproduced antimicrobial peptide triggers inflammation that the body can’t properly shut off. An estimated 10% of adults have rosacea, most commonly women between ages 30 and 50, and the condition results from a collision of genetic vulnerability, immune dysfunction, microscopic skin mites, and environmental triggers that together push facial skin into a chronic inflammatory state.
The Core Immune Malfunction
Your skin naturally produces a small antimicrobial peptide called LL-37, part of a family of molecules that help fight off bacteria and other invaders. In people with rosacea, the skin produces far more LL-37 than normal. This excess sets off a specific inflammatory alarm system: LL-37 gets absorbed into immune cells called macrophages and destabilizes their internal structures, which activates a protein complex called the inflammasome. Once switched on, this complex triggers the release of powerful inflammatory signals that recruit waves of additional immune cells to the skin.
The result is the redness, swelling, and visible bumps that define rosacea. In mouse studies, injecting LL-37 into the skin produced rosacea-like inflammation, while blocking the inflammasome nearly eliminated those symptoms. This tells us that the inflammasome pathway isn’t just involved in rosacea; it’s a central driver.
Mast cells, another type of immune cell abundant in facial skin, make the problem worse. Mast cells are one of the primary sources of both LL-37 and the enzyme that converts it into its active, inflammatory form. When LL-37 activates mast cells, they release a burst of inflammatory chemicals, tissue-degrading enzymes, and signals that dilate blood vessels and promote the growth of new (often visible) blood vessels. People with rosacea have abnormally high levels of these tissue-degrading enzymes in their facial skin, which over time contributes to the thickened, textured skin some patients develop.
Genetics Load the Gun
Rosacea runs in families, and genome-wide studies have identified several genetic regions that increase susceptibility. The strongest associations involve a cluster of immune-related genes on chromosome 6, particularly in the HLA region, which governs how your immune system recognizes threats. Specific HLA gene variants, including HLA-DRB1*03:01 and HLA-DQB1*02:01, are significantly associated with rosacea risk. One variant, HLA-DQB1*03:03, appears to increase both the risk and severity of symptoms by influencing certain white blood cell levels.
Beyond the HLA region, other genetic contributors include the gene for toll-like receptor 2 (TLR2), a sensor on skin cells that detects microorganisms and environmental threats. People with rosacea show marked overexpression of TLR2, which makes their skin hypersensitive to stimuli that wouldn’t bother someone else. The CAMP gene, which encodes the precursor for LL-37, also plays a role: when its regulation goes awry, the skin produces too much of the peptide that drives inflammation. Genes involved in skin pigmentation, including those that regulate melanin synthesis, may explain why lighter-skinned individuals tend to be more susceptible, though rosacea occurs across all skin tones.
Demodex Mites and the Skin Microbiome
Tiny mites called Demodex folliculorum live in the hair follicles of virtually every adult’s face. In healthy skin, their numbers stay low. In rosacea, particularly the subtype with bumps and pustules, mite density can spike dramatically. Studies using standardized skin biopsies found that a density above 5 mites per square centimeter on the skin surface, or above 10 per square centimeter in deeper layers, predicted a rosacea diagnosis with about 99% sensitivity and 96% specificity. Some patients had densities reaching over 200 mites per square centimeter.
The mites themselves aren’t necessarily the primary cause, but they amplify the immune malfunction already in progress. When Demodex die and decompose in follicles, they release bacteria and proteins that further activate TLR2 and stimulate even more LL-37 production. About half of patients with the early, redness-only form of rosacea already show abnormally high mite densities, suggesting that Demodex proliferation begins before the condition progresses to its more inflammatory stages.
How UV Light and Heat Feed the Cycle
Sun exposure is the single most commonly reported rosacea trigger, affecting 81% of patients in a large National Rosacea Society survey. Ultraviolet radiation damages skin through several converging pathways. It generates reactive oxygen species that overwhelm the skin’s natural antioxidant defenses, tilting the balance toward chronic oxidative stress. UV also activates TLR2 through a stress response in skin cells, which circles back to the same innate immune pathway that produces excess LL-37.
What makes rosacea skin uniquely vulnerable to sun is that the LL-37 already present in excess actually amplifies UV’s effects. It enhances both the inflammatory and blood-vessel-growing responses to UV exposure, increasing the release of inflammatory signals and boosting the ability of blood vessel cells to proliferate. This creates a vicious cycle: sun exposure worsens inflammation, which produces more LL-37, which makes the skin even more reactive to the next round of sun exposure.
Nerve and Blood Vessel Dysfunction
The persistent redness and flushing of rosacea aren’t just cosmetic. They reflect real changes in how facial nerves and blood vessels communicate. Gene expression studies of rosacea skin show increased activity of several signaling molecules that regulate blood vessel dilation, including those in the serotonin, histamine, and adrenaline receptor families. At the same time, receptors that would normally counterbalance these signals and constrict vessels show reduced activity.
Sensory nerves in rosacea skin become hypersensitive, releasing neuropeptides that directly act on blood vessel walls to keep them dilated. This is why many patients experience burning, stinging, and flushing in response to stimuli like temperature changes, spicy food, or emotional stress. The nerves aren’t just reacting to inflammation; they’re actively participating in it, creating a neuroimmune feedback loop where nerve signals worsen inflammation and inflammation further sensitizes nerves.
The Gut Connection
A growing body of evidence links rosacea to imbalances in the gut. A meta-analysis of six studies found that 35.8% of rosacea patients had small intestinal bacterial overgrowth (SIBO), compared to just 9.4% of controls. Rosacea patients were 3.5 times more likely to have SIBO than people without the condition. Treating the bacterial overgrowth with targeted antibiotics improved skin symptoms in these patients, suggesting the connection is more than coincidental. The mechanism likely involves gut bacteria releasing inflammatory signals that enter the bloodstream and reach the skin, though the exact pathway is still being mapped. SIBO testing is increasingly considered for patients whose rosacea doesn’t respond well to standard skin-directed treatments.
Common Triggers and What They Share
Surveys of rosacea patients reveal a consistent pattern in what provokes flares. The top triggers, with the percentage of patients who report them:
- Sun exposure: 81%
- Emotional stress: 79%
- Hot weather: 75%
- Wind: 57%
- Strenuous exercise: 56%
- Alcohol: 52%
- Hot baths: 51%
- Cold weather: 46%
- Spicy foods: 45%
Nearly all of these triggers share something in common: they either increase blood flow to the face, activate sensory nerves, or generate oxidative stress in the skin. Hot environments, exercise, and alcohol all dilate blood vessels. Stress activates the same neuroimmune pathways already dysregulated in rosacea. Wind and cold damage the skin barrier, letting irritants penetrate more easily. Spicy foods contain capsaicin, which directly stimulates the same sensory nerve receptors that are overexpressed in rosacea skin. The triggers don’t cause rosacea on their own, but in skin that’s already primed by genetics and immune dysfunction, they’re enough to tip the balance into a visible flare.
Why It Gets Worse Over Time
Rosacea tends to be progressive because its underlying mechanisms are self-reinforcing. Inflammation damages blood vessels, which become permanently dilated (visible as telangiectasia). Damaged vessels leak more inflammatory cells into the skin. LL-37 promotes the growth of new, fragile blood vessels that are even more prone to dilation and leakage. Tissue-degrading enzymes break down the structural proteins that normally keep skin firm and resilient, leading to the thickened, bumpy texture seen in advanced cases.
The modern classification of rosacea reflects this complexity. Rather than sorting patients into rigid subtypes, clinicians now describe rosacea by its visible features: persistent central facial redness, visible blood vessels, papules and pustules, flushing episodes, and eye involvement. Most patients have overlapping features, and recognizing the specific combination guides treatment more effectively than a single subtype label. About 57% of patients show primarily redness and visible vessels, while 43% develop inflammatory bumps. Eye involvement affects roughly 11% of diagnosed cases, often causing dryness, irritation, and visible blood vessels on the eyelids.